NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for…
DetailsNEW YORK–(BUSINESS WIRE)–Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) between February 13, 2020…
DetailsBENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) securities between February 13, 2020 and September 4, 2020, inclusive (the “Class…
DetailsNEW YORK–(BUSINESS WIRE)–Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) between February 13, 2020 and September 4, 2020 (the “Class Period”). The lawsuit filed in…
DetailsLOS ANGELES–(BUSINESS WIRE)–VGC, LLP (“VGC”) represented Subversive Real Estate Acquisition REIT LP (“Subversive REIT”) in the recently announced negotiation of over US$200 million in real estate deals, including $182.8 million comprising a qualifying transaction composed of 15 cannabis industrial cultivation, manufacturing, processing and retail properties in nine states, including California, Ohio, Florida, Nevada, Washington, Arizona,…
DetailsLONDON–(BUSINESS WIRE)–Technavio has been monitoring the cannabidiol oil (CBD oil) market and it is poised to grow by USD 3.52 bn during 2020-2024, progressing at a CAGR of over 32% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although…
DetailsTORONTO–(BUSINESS WIRE)–Subversive Real Estate Acquisition REIT LP (NEO: SVX.U) (NEO: SVX.RT.U) (OTCBB: SBVRF) (the “REIT LP”) today announced that the REIT LP will host a conference call to discuss its previously announced Qualifying Transaction to become the second publicly traded cannabis REIT, and to become a leading real estate capital provider for prominent cannabis operators…
DetailsLONDON–(BUSINESS WIRE)–The global medical marijuana market size is poised to grow by USD 22.33 billion during 2020-2024, progressing at a CAGR of over 24% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.…
DetailsDENVER–(BUSINESS WIRE)–Leading cannabis operator Green Dragon today announced its entry into the Florida medical cannabis market. Along with its vertically integrated cultivation and processing facilities that went online earlier this year, the company is expanding its footprint in coming months with operations spanning extraction, infused-product manufacturing and retail dispensaries to serve Florida patients statewide. Green…
DetailsNEW YORK–(BUSINESS WIRE)–Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) resulting from allegations that Aurora might have issued misleading information to the investing public. If you purchased Aurora securities, and/or would like to discuss…
DetailsNEW YORK–(BUSINESS WIRE)–Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced the launch of the company’s first internally developed cannabis lifestyle brand, Seed & Strain. The Company’s inaugural venture into national brand launches, Seed & Strain was created to provide both adult use and medical consumers…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the publication of data demonstrating the benefit of continuous proteinuria reduction on kidney survival in patients with focal segmental glomerulosclerosis (FSGS) and underscoring the utility of proteinuria as a clinically meaningful…
Details